Skip to main content
Search
Main content
Suvankar Pal profile

Prof Suvankar Pal

Group Leader

Clinically active academic neurologist specialising in motor neuron disease

Biography

Suvankar Pal is Consultant Neurologist, and Professor of Neurodegenerative Disorders and Clinical Trials at the University of Edinburgh.  He is co-lead investigator of the UK wide innovative multi-arm multi-stage MND SMART trial, the Scottish Motor Neuron Disease Register (CARE-MND), a Deputy Director at the Anne Rowling Clinic, a co-lead of the recently awarded MRC Centre of Research Excellence (CoRE) in Clinical Trial Innovation and Clinical Lead for Neurology at NHS Forth Valley.   His clinical and research interests are focused on improving outcomes for people with neurodegenerative disorders, including accelerating early and accurate diagnoses, leading population-based disease registries for longitudinal deep clinical phenotyping, digital and wet lab biomarker development/reverse translation, and delivery of innovative clinical trials. 

Suvankar graduated in Medicine with Distinction in Clinical Sciences, and Neurosciences, from King’s College London in 2001, completed basic medical training at the Royal Postgraduate Medical School (Hammersmith Hospital and National Hospital for Neurology), and Royal Free Hospital, before completing his Doctoral research investigating novel molecular diagnostic strategies in Prion disease and supporting recruitment to the PRION1 trial at the MRC Prion Unit Institute of Neurology UCL.  He completed higher specialist training in neurology in Edinburgh and was appointed to a Consultant Neurologist position in 2011 at NHS Forth Valley and the University of Edinburgh.  Suvankar completed a Postgraduate Certificate in Medical Education from UCL/Royal College of Physicians in 2012 and is a Fellow of the Higher Education Academy. He was awarded an inaugural NHS Scotland Research Fellowship in 2012, and appointed to a Clinical Senior Lecturer Position at the Centre for Clinical Brain Sciences in 2018.  He was awarded a Personal Chair in Neurodegenerative Disorders and Clinical Trials at the University of Edinburgh in 2023. 

Suvankar is passionate about promoting equity of access, and diversity in research. He has a keen interest in education, mentorship, and training, and has successfully supported many undergraduate and postgraduate students from varying disciplines.

News

Key publications

BMJ open
Published
Digital App for Speech and Health Monitoring Study (DASH): protocol for a prospective longitudinal case-control observational study for developing speech datasets in neurodegenerative disorders and dementia
Authors
Johnny Tam, Christine Weaver, Amarachi Ihenacho, Judith Newton, Bruce Virgo, Steven Barrett, Jonathan Neale, David Perry, Alice Smith, Siddharthan Chandran, Oliver Watts, Suvankar Pal, DASH Consortium
Digital App for Speech and Health Monitoring Study (DASH): protocol for a prospective longitudinal case-control observational study for developing speech datasets in neurodegenerative disorders and dementia
Journal of the neurological sciences
Published
Functional cognitive disorder in Alzheimer's disease
Authors
Verónica Cabreira, Martin Zeidler, Laura McWhirter, Suvankar Pal, Jon Stone, Alan Carson
Functional cognitive disorder in Alzheimer's disease
Cell genomics
Published
Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data
Authors
Sara Saez-Atienzar, Cleide Dos Santos Souza, Ruth Chia, Selina N Beal, Ileana Lorenzini, Ruili Huang, Jennifer Levy, Camelia Burciu, Jinhui Ding, J Raphael Gibbs, Ashley Jones, Ramita Dewan, Viviana Pensato, Silvia Peverelli, Lucia Corrado, Joke J F A van Vugt, Wouter van Rheenen, Ceren Tunca, Elif Bayraktar, Menghang Xia, International ALS Genomics Consortium, ITALSGEN Consortium, SLAGEN Consortium, Project MinE ALS Sequencing Consortium, Alfredo Iacoangeli, Aleksey Shatunov, Cinzia Tiloca, Nicola Ticozzi, Federico Verde, Letizia Mazzini, Kevin Kenna, Ahmad Al Khleifat, Sarah Opie-Martin, Flavia Raggi, Massimiliano Filosto, Stefano Cotti Piccinelli, Alessandro Padovani, Stella Gagliardi, Maurizio Inghilleri, Alessandra Ferlini, Rosario Vasta, Andrea Calvo, Cristina Moglia, Antonio Canosa, Umberto Manera, Maurizio Grassano, Jessica Mandrioli, Gabriele Mora, Christian Lunetta, Raffaella Tanel, Francesca Trojsi, Patrizio Cardinali, Salvatore Gallone, Maura Brunetti, Daniela Galimberti, Maria Serpente, Chiara Fenoglio, Elio Scarpini, Giacomo P Comi, Stefania Corti, Roberto Del Bo, Mauro Ceroni, Giuseppe Lauria Pinter, Franco Taroni, Eleonora Dalla Bella, Enrica Bersano, Charles J Curtis, Sang Hyuck Lee, Raymond Chung, Hamel Patel, Karen E Morrison, Johnathan Cooper-Knock, Pamela J Shaw, Gerome Breen, Richard J B Dobson, Clifton L Dalgard, American Genome Center, Sonja W Scholz, Ammar Al-Chalabi, Leonard H van den Berg, Russell McLaughlin, Orla Hardiman, Cristina Cereda, Gianni Sorarù, Sandra D'Alfonso, Siddharthan Chandran, Suvankar Pal, Antonia Ratti, Cinzia Gellera, Kory Johnson, Tara Doucet-O'Hare, Nicholas Pasternack, Tongguang Wang, Avindra Nath, Gabriele Siciliano, Vincenzo Silani, Ayşe Nazlı Başak, Jan H Veldink, William Camu, Jonathan D Glass, John E Landers, Adriano Chiò, Rita Sattler, Christopher E Shaw, Laura Ferraiuolo, Isabella Fogh, Bryan J Traynor
Mechanism-free repurposing of drugs for C9orf72-related ALS/FTD using large-scale genomic data
Lancet Neurol
Published
Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease (MND SMART): stage two interim analysis from the first cycle of a phase 3, multiarm, multistage, randomised, adaptive platform trial.
Authors
Suvankar Pal, Jeremy Chataway, Robert Swingler, Malcolm R Macleod, Neil O Carragher, Giles Hardingham, Bhuvaneish Thangaraj Selvaraj, Colin Smith, Charis Wong, Judith Newton, Dawn Lyle, Amy Stenson, Rachel S Dakin, Amarachi Ihenacho, Shuna Colville, Arpan R Mehta, Nigel Stallard, James R Carpenter, Richard A Parker, Catriona Keerie, Christopher J Weir, Bruce Virgo, Stevie Morris, Nicola Waters, Beverley Gray, Donald MacDonald, Euan MacDonald, Mahesh K B Parmar, Siddharthan Chandran,
Safety and efficacy of memantine and trazodone versus placebo for motor neuron disease (MND SMART): stage two interim analysis from the first cycle of a phase 3, multiarm, multistage, randomised, adaptive platform trial.